Gujarat Health Minister Praful Pansheriya Announces Zero-Tolerance Policy Against Fake and Illegal Medicines

Gandhinagar: Gujarat Health Minister Praful Pansheriya has directed officials to adopt a zero-tolerance approach against fake, substandard and illegally sold medicines, stressing that strict legal action should be taken against those putting public health at risk.The minister issued the directions during a high-level review meeting at the Gujarat Secretariat, where the enforcement activities of the state's Food and Drug Control Administration (FDCA) were reviewed.During the meeting, officials presented details of regulatory action taken after inspections conducted across the state.According to the review, the FDCA cancelled the sales licences of 50 medicine shops after significant irregularities were found during inspections. The department also ordered the closure of two drug manufacturing units, suspended licences of eight manufacturers and revoked manufacturing licences of 11 medicines.

Minister warns against compromising patient safety

Pansheriya said the government would not compromise on the health and safety of citizens.He directed the FDCA to maintain strict monitoring of medicine manufacturers, distributors and sellers and ensure that action is taken against those involved in illegal practices.The minister's comments come amid increased regulatory focus on counterfeit, substandard and unauthorised medicines, where authorities have been conducting inspections and taking action against violations.

FDCA steps up inspections

The Food and Drug Control Administration carries out inspections of pharmaceutical units, medical stores and supply chains to check compliance with drug safety regulations.Officials review issues including manufacturing practices, storage conditions, sale records, licences and the authenticity of medicines.Recent enforcement actions in Gujarat have included seizure of suspected medicines, suspension of licences and investigations into firms allegedly involved in irregular sales or manufacturing practices.

Focus on protecting public health

Fake or substandard medicines can pose serious risks because they may contain incorrect ingredients, inadequate active substances or fail to meet required quality standards.The Gujarat government's latest directions focus on strengthening regulatory checks and ensuring accountability across the medicine supply chain.The FDCA will continue inspections and further action will depend on findings from investigations and regulatory procedures.